The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation

Bibliographic Details
Main Authors:	A Takeda, J Jones, E Loveman, S Tan, A Clegg
Format:	Article
Language:	English
Published:	NIHR Journals Library 2007-05-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta11190

Gemcitabine for the treatment of metastatic breast cancer
by: J Jones, et al.
Published: (2009-09-01)

The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation
by: E Loveman, et al.
Published: (2010-03-01)

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
by: J Picot, et al.
Published: (2009-09-01)

The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation
by: A.J. Clegg, et al.
Published: (2002-01-01)

The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation
by: Emma Loveman, et al.
Published: (2015-03-01)

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation
by: A Clegg, et al.
Published: (2005-11-01)

The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review
by: J Bryant, et al.
Published: (2005-09-01)

The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation
by: Emma Loveman, et al.
Published: (2014-01-01)

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer
by: A. Clegg, et al.
Published: (2001-01-01)

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
by: E Loveman, et al.
Published: (2006-01-01)

Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation.
by: Bryant, et al.
Published: (2002-01-01)

The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation
by: E Loveman, et al.
Published: (2003-08-01)

The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review
by: E Loveman, et al.
Published: (2008-04-01)

The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review
by: E Loveman, et al.
Published: (2011-01-01)

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer
by: S. Ward, et al.
Published: (2001-01-01)

Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation.
by: Bryant, J, et al.
Published: (2002)

The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation
by: Debbie Hartwell, et al.
Published: (2014-10-01)

Matters arising: On the cost-effectiveness for the Italian National Health Service of nab-paclitaxel plus gemcitabine vs gemcitabine alone in metastatic pancreatic cancer
by: Carlo Lazzaro
Published: (2024-12-01)

On cost-effectiveness analysis, quality-adjusted life years, and cost-effectiveness threshold values of gemcitabine plus nab-paclitaxel versus gemcitabine alone in metastatic pancreatic cancer in the French setting
by: Carlo Lazzaro
Published: (2024-08-01)

The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation.
by: Lewis, et al.
Published: (2002-01-01)

French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel gemcitabine alone as second-line treatment in metastatic pancreatic cancer patients
by: Amaury Demaziere, et al.
Published: (2024-06-01)

The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation
by: AJ Clegg, et al.
Published: (2010-06-01)

Evaluating nivolumab plus gemcitabine–cisplatin’s cost-effectiveness for aUC in China
by: Kehui Meng, et al.
Published: (2024-11-01)

Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness
by: Karen Pickett, et al.
Published: (2015-10-01)

Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation
by: J Colquitt, et al.
Published: (2008-05-01)

Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation
by: E Loveman, et al.
Published: (2012-05-01)

Cost-effectiveness analysis of nimotuzumab combined with gemcitabine for K-Ras wild type locally advanced or metastatic pancreatic cancer in China
by: Rong Long, et al.
Published: (2025-02-01)

A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
by: Spinelli Gian, et al.
Published: (2006-05-01)

Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma
by: Yang Q, et al.
Published: (2022-04-01)

The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.
by: J Picot, et al.
Published: (2011-12-01)

Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation
by: A Murray, et al.
Published: (2006-11-01)

Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
by: C Green, et al.
Published: (2005-03-01)

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
by: Narayan Rajan, et al.
Published: (2014-12-01)

The cost-effectiveness of neoadjuvant chemotherapy in women with locally advanced breast cancer: Adriamycin and cyclophosphamide in comparison with paclitaxel and gemcitabine
by: Javad Javan-Noughabi, et al.
Published: (2018-01-01)

The clinical effectiveness and cost-effectiveness of routine dental checks: a systematic review and economic evaluation
by: C. Davenport, et al.
Published: (2003-01-01)

Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation
by: JL Colquitt, et al.
Published: (2011-07-01)

The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation
by: Pavey, T, et al.
Published: (2011)

Successful Remission of Hemolytic-Uremic Syndrome during the Third-line Weekly Gemcitabine for Metastatic Breast Cancer
by: Victor C. Kok, et al.
Published: (2014-01-01)

Successful Remission of Hemolytic-Uremic Syndrome During the Third-line Weekly Gemcitabine for Metastatic Breast Cancer
by: Victor C. Kok, et al.
Published: (2014-03-01)

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation
by: T Brown, et al.
Published: (2013-07-01)

The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation

Similar Items

Similar Items